N-[3-(4-chlorbenzoyl)-4-chlorphenyl]-2-[(4-chlorphenylsulfonyl)-amino]-5- -haloidbenzamids, possessing activity at experimental trichoceplaliasis
RU1786022C
Method of 5-chloroanthranilic acid 4-chloroanilide synthesis
SU1745740A1
Method of echinococcosis modelling
RU1794941C
N-(3-nitro-4-chlorophenylsulfonyl)-5-chloroanthranilic acid as an intermediate for synthesis of n-(4-chlorophenyl)-2-(3-nitro-4-chlorophenylsulfonyl)amino-5- chlorobenzamide showing antitrichocephaliasis activity
SU1685936A1
N-(haloidophenyl)-2-[(benzo-2,1,3-thiadiazol-4-sulphonyl)amino]-5-- chlorobenzamides, showing activity in experimental trichocephaliasis
SU1685935A1
2-[(benzo-2
SU1754712A1
N-(3-nitro-4-chlorophenylsulfonyl)-anthranilic acid as an intermediate for synthesis of n-(4-chlorophenyl)-2-[(3-nitro- 4-chlorophenylsulfonyl)-amino]-5-bromobenzamide, showing antitrichocephaliasis activity
SU1685937A1
2-[(7-bromobenzo-2
SU1681331A1
Method for modeling circulation of malaria infection agent
SU1623131A1
2-oxy-3,5-dichloro-n-[3-chloro-4-(4-chloronaphthyloxy-1)] phenylbensamide displaying activity in hymenolipiasis cases
SU1587050A1
Derivatives of (7-bromobenzo-2,1,3-thiadiazol-4-sulfonyl)-amine as intermediate products in synthesis of benzamide displaying antihelmint activity
SU1547248A1
1-bromo-4(2-nitro-4-chlorophenoxy)-naphthalin as initial product for synthesis of 2-oxy-3,5-diiodo-n-/2-(4-bromonaphthoxy-1)-5-chlorophenyli/-benzamide possessing antimalaria activity
SU1556058A1
2-(4-halogennaphthoxy-1)5-choloraniline as intemediate compound
SU1587042A1
1-chloro-4-(2-nitro-4-chlorophenoxy)naphthalene as intermediate product in synthesis of chlorophenylbenzamide displaying antimalaria activity
SU1565448A1
Method of determining resistance of mosquito to organic phosphorus insecticide
SU1649364A1
Agent for revealing fistula ducts in actinomycosis cases
SU1584952A1
Method of preparing actinolisate
SU1563700A1
Method of obtaining biomass of malaria exciter plasmodium falciparum
2-(n-toluenesulfonyl)-1,2,3,4-tetrahydropyrasin (1, 2-a)-benzimidasol as intermediate product in the synthesis of 2-substituted 1,2,3,4-tetrahydropyrasin (1, 2-a)-benzimidasols, possessing biological activity
